Research visual

Health Research

Double threat: concurrent use of opioids and benzodiazepines

Pacholski EB, Weber JJ, Sandefur T, Cooley J, Gaddy RR. Double threat: Concurrent use of opioids and benzodiazepines. Poster presented at: Pharmacy Quality Alliance Annual Meeting. May 17-19, 2017. Baltimore, MD.

http://apps.humana.com/marketing/documents.asp?file=3288727

Significant improvement of severe low back pain after breast reduction surgery due to macromastia, a case report

Restrepo A. Significant improvement of severe low back pain after breast reduction surgery due to macromastia, a case report. Poster presentation at: American Academy of Physical Medicine and Rehabilitation Annual Assembly and Technical Exhibition. November 13-16, 2014; San Diego, CA.

http://apps.humana.com/marketing/documents.asp?file=2645214

Economic burden of pain in a national health insurance plan

Pasquale M, Dufour R, Reiners AT, et al. Economic burden of pain in a national health insurance plan. Poster presentation at: Academy of Managed Care Pharmacy 25th Annual Meeting and Expo. April 2-5, 2013. San Diego, CA.

http://apps.humana.com/marketing/documents.asp?file=2574000

Evaluation of narcotic/acetaminophen prescription patterns and acetaminophen toxicity in a managed care population

Xu Y. Evaluation of narcotic/acetaminophen prescription patterns and acetaminophen toxicity in a managed care population. Podium presentation at: Academy of Managed Care Pharmacy Annual Meeting. April, 2010; San Diego, CA.

Impact of celecoxib restrictions in Medicare beneficiaries with arthritis

Louder A.  Impact of celecoxib restrictions in Medicare beneficiaries with arthritis. Podium presentation at: Academy of Managed Care Pharmacy Educational Conference. October, 2010. St. Louis, MO.

Use and costs of health care resources in fibromyalgia: a case-control comparison

Uribe C. Use and costs of health care resources in fibromyalgia: a case-control comparison. Podium presentation at: Academy of Managed Care Pharmacy 22nd Annual Meeting. April, 2010; San Diego, CA.

Pain conditions ranked by healthcare costs for members of a national health plan

Pasquale MK, Dufour R, Schaaf D, et al. Pain conditions ranked by healthcare costs for members of a national health plan.  Pain Pract. 2014;14(2):117-31.

http://www.ncbi.nlm.nih.gov/pubmed/23601620

Longitudinal evaluation of health care utilization and costs during the first three years after a new diagnosis of fibromyalgia

Sanchez RJ, Uribe C, Li H, et al. Longitudinal evaluation of health care utilization and costs during the first three years after a new diagnosis of fibromyalgia. Curr Med Res Opin. 2011;27(3):663-71.

Longitudinal evaluation of health care utilization and costs during the first three years after a new diagnosis of fibro…

Inefficiencies in osteoarthritis and chronic low back pain management

Pasquale MK, Dufour R, Joshi AV, et al. Inefficiencies in osteoarthritis and chronic low back pain management. Am J Manag Care. 2013;19(10):816-23.

Inefficiencies in osteoarthritis and chronic low back pain management. - PubMed - NCBI

Impact of potential pregabalin or duloxetine drug-drug interactions on health care costs and utilization among Medicare members with fibromyalgia

Ellis JJ, Sadosky AB, Ten Eyck LL, et al. Impact of potential pregabalin or duloxetine drug-drug interactions on health care costs and utilization among Medicare members with fibromyalgia. Clinicoecon Outcomes Res. 2014;14(6):389-99.

Impact of potential pregabalin or duloxetine drug-drug interactions on health care costs and utilization among Medicare …

Impact of celecoxib restrictions in Medicare beneficiaries with arthritis

Louder AM, Joshi AV, Ball AT, Cappelleri JC, Deminski MC, Sanchez RJ. Impact of celecoxib restrictions in Medicare beneficiaries with arthritis. Am J Mang Care. 2011;17(7):503-12.

Impact of Celecoxib restrictions in medicare beneficiaries with arthritis. - PubMed - NCBI

Impact of a step-therapy protocol for pregabalin on healthcare utilization and expenditures in a commercial population.

Udall M, Louder A, Suehs BT, Cappelleri JC, Joshi AV, Patel NC. Impact of a step-therapy protocol for pregabalin on healthcare utilization and expenditures in a commercial population. J Med Econ. 2013;16(6):784-92.

Impact of a step-therapy protocol for pregabalin on healthcare utilization and expenditures in a commercial population. …

Impact of a pregabalin step therapy policy among Medicare Advantage beneficiaries

Suehs BT, Louder A, Udall M, Cappelleri JC, Joshi AV, Patel NC. Impact of a pregabalin step therapy policy among Medicare Advantage beneficiaries. Pain Pract. 2014;14(5):419-26.

Impact of a pregabalin step therapy policy among medicare advantage beneficiaries. - PubMed - NCBI

Health care utilization and costs among patients with fibromyalgia in an insured population

Palacio AM, Uribe CL, Hua Li, et al. Health care utilization and costs among patients with fibromyalgia in an insured population. Am J Pharm Benefits. 2011;3(4):212-220.

Financial and clinical characteristics of fibromyalgia: a case-control comparison

Palacio A, Uribe CL, Li H, et al. Financial and clinical characteristics of fibromyalgia: a case-control comparison. Am J Manag Care. 2010;16(5 Suppl):S118-25.

Financial and clinical characteristics of fibromyalgia: a case-control comparison. - PubMed - NCBI

Double threat: concurrent use of opioids and benzodiazepines

Pacholski EB, Weber JJ, Sandefur T, Cooley J, Gaddy RR. Double threat: Concurrent use of opioids and benzodiazepines. Poster presented at: Pharmacy Quality Alliance Annual Meeting. May 17-19, 2017. Baltimore, MD.

http://apps.humana.com/marketing/documents.asp?file=3288727

Significant improvement of severe low back pain after breast reduction surgery due to macromastia, a case report

Restrepo A. Significant improvement of severe low back pain after breast reduction surgery due to macromastia, a case report. Poster presentation at: American Academy of Physical Medicine and Rehabilitation Annual Assembly and Technical Exhibition. November 13-16, 2014; San Diego, CA.

http://apps.humana.com/marketing/documents.asp?file=2645214

Economic burden of pain in a national health insurance plan

Pasquale M, Dufour R, Reiners AT, et al. Economic burden of pain in a national health insurance plan. Poster presentation at: Academy of Managed Care Pharmacy 25th Annual Meeting and Expo. April 2-5, 2013. San Diego, CA.

http://apps.humana.com/marketing/documents.asp?file=2574000

Evaluation of narcotic/acetaminophen prescription patterns and acetaminophen toxicity in a managed care population

Xu Y. Evaluation of narcotic/acetaminophen prescription patterns and acetaminophen toxicity in a managed care population. Podium presentation at: Academy of Managed Care Pharmacy Annual Meeting. April, 2010; San Diego, CA.

Impact of celecoxib restrictions in Medicare beneficiaries with arthritis

Louder A.  Impact of celecoxib restrictions in Medicare beneficiaries with arthritis. Podium presentation at: Academy of Managed Care Pharmacy Educational Conference. October, 2010. St. Louis, MO.

Use and costs of health care resources in fibromyalgia: a case-control comparison

Uribe C. Use and costs of health care resources in fibromyalgia: a case-control comparison. Podium presentation at: Academy of Managed Care Pharmacy 22nd Annual Meeting. April, 2010; San Diego, CA.

Pain conditions ranked by healthcare costs for members of a national health plan

Pasquale MK, Dufour R, Schaaf D, et al. Pain conditions ranked by healthcare costs for members of a national health plan.  Pain Pract. 2014;14(2):117-31.

http://www.ncbi.nlm.nih.gov/pubmed/23601620

Longitudinal evaluation of health care utilization and costs during the first three years after a new diagnosis of fibromyalgia

Sanchez RJ, Uribe C, Li H, et al. Longitudinal evaluation of health care utilization and costs during the first three years after a new diagnosis of fibromyalgia. Curr Med Res Opin. 2011;27(3):663-71.

Longitudinal evaluation of health care utilization and costs during the first three years after a new diagnosis of fibro…

Inefficiencies in osteoarthritis and chronic low back pain management

Pasquale MK, Dufour R, Joshi AV, et al. Inefficiencies in osteoarthritis and chronic low back pain management. Am J Manag Care. 2013;19(10):816-23.

Inefficiencies in osteoarthritis and chronic low back pain management. - PubMed - NCBI

Impact of potential pregabalin or duloxetine drug-drug interactions on health care costs and utilization among Medicare members with fibromyalgia

Ellis JJ, Sadosky AB, Ten Eyck LL, et al. Impact of potential pregabalin or duloxetine drug-drug interactions on health care costs and utilization among Medicare members with fibromyalgia. Clinicoecon Outcomes Res. 2014;14(6):389-99.

Impact of potential pregabalin or duloxetine drug-drug interactions on health care costs and utilization among Medicare …

Impact of celecoxib restrictions in Medicare beneficiaries with arthritis

Louder AM, Joshi AV, Ball AT, Cappelleri JC, Deminski MC, Sanchez RJ. Impact of celecoxib restrictions in Medicare beneficiaries with arthritis. Am J Mang Care. 2011;17(7):503-12.

Impact of Celecoxib restrictions in medicare beneficiaries with arthritis. - PubMed - NCBI

Impact of a step-therapy protocol for pregabalin on healthcare utilization and expenditures in a commercial population.

Udall M, Louder A, Suehs BT, Cappelleri JC, Joshi AV, Patel NC. Impact of a step-therapy protocol for pregabalin on healthcare utilization and expenditures in a commercial population. J Med Econ. 2013;16(6):784-92.

Impact of a step-therapy protocol for pregabalin on healthcare utilization and expenditures in a commercial population. …

Impact of a pregabalin step therapy policy among Medicare Advantage beneficiaries

Suehs BT, Louder A, Udall M, Cappelleri JC, Joshi AV, Patel NC. Impact of a pregabalin step therapy policy among Medicare Advantage beneficiaries. Pain Pract. 2014;14(5):419-26.

Impact of a pregabalin step therapy policy among medicare advantage beneficiaries. - PubMed - NCBI

Health care utilization and costs among patients with fibromyalgia in an insured population

Palacio AM, Uribe CL, Hua Li, et al. Health care utilization and costs among patients with fibromyalgia in an insured population. Am J Pharm Benefits. 2011;3(4):212-220.

Financial and clinical characteristics of fibromyalgia: a case-control comparison

Palacio A, Uribe CL, Li H, et al. Financial and clinical characteristics of fibromyalgia: a case-control comparison. Am J Manag Care. 2010;16(5 Suppl):S118-25.

Financial and clinical characteristics of fibromyalgia: a case-control comparison. - PubMed - NCBI